The LaunchPad for Diabetes program is an internal, translational research fund supporting collaborative research projects proposing innovative solutions for the treatment of Type 1 and Type 2 diabetes. The goal of this program is to support/develop translational research projects that address unmet clinical needs and lead to improvements in care of patients with diabetes mellitus. Examples of desirable outcomes include improved diagnosis and treatment of disease through new medical devices, biomarkers or diagnostics, therapeutic targets and agents, or new clinical adoption of existing tools. Although not required, it is anticipated that most projects will result in new intellectual property, commercial partnerships, or lead to start-up company creation. On average, the program supports 4-6 projects averaging $80,000 each for 12 months.

The LaunchPad program is supported through a generous gift from Paul and Diane Manning.

Eligibility Criteria:

• Permanent, full-time, tenure-track faculty at professorial rank (assistant, associate, full).

• Each proposal must have at least two co-investigators, one that has a primary or secondary appointment in the School of Medicine and one clinical collaborator (medical doctor, nurse or professional who sees patients).

• Eligible investigators may submit more than one proposal.

The full Request for 2019-20 Applications 


Contact: Sharon Krueger (